May 19, 2006
FDA Grants Coley Treatment "Fast Track"
FDA Grants Coley Treatment "Fast Track"
MSN MoneyCentral – WELLESLEY, Mass. (AP) – Coley Pharmaceutical Group Inc. said Wednesday that the Food and Drug Administration granted "fast-track" status to the company's proposed Actilon treatment for Hepatitis C in patients who have failed other therapies. With the
Filed under Liver Related News by admin





